PlainRecalls
FDA Drug Moderate Class II Ongoing

Lanthanum Carbonate Chewable Tablets, 1000mg, 10-count bottle, Rx only, Manufactured for Cipla USA, NDC 69097-0936-98

Reported: November 20, 2024 Initiated: October 23, 2024 #D-0043-2025

Product Description

Lanthanum Carbonate Chewable Tablets, 1000mg, 10-count bottle, Rx only, Manufactured for Cipla USA, NDC 69097-0936-98

Reason for Recall

Failed Tablet/Capsule Specifications: Complaints received of crushed and broken tablets.

Details

Recalling Firm
Cipla USA, Inc.
Units Affected
1,875 boxes (cipla and exlan)
Distribution
USA nationwide.
Location
Warren, NJ

Frequently Asked Questions

What product was recalled?
Lanthanum Carbonate Chewable Tablets, 1000mg, 10-count bottle, Rx only, Manufactured for Cipla USA, NDC 69097-0936-98. Recalled by Cipla USA, Inc.. Units affected: 1,875 boxes (cipla and exlan).
Why was this product recalled?
Failed Tablet/Capsule Specifications: Complaints received of crushed and broken tablets.
Which agency issued this recall?
This recall was issued by the FDA Drug on November 20, 2024. Severity: Moderate. Recall number: D-0043-2025.